Pricing Log in Create free account
Saturday 7 November 2026 Export AHR’s income statement to Excel — free account

American Healthcare REIT, Inc.

AHR Real Estate Reit Healthcare Facilities

American Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 9.15% from fiscal 2024.

Revenue
+29.5%
EPS
−57.6%
Free cash flow
+9.53%
Total debt
−64.6%

Quarter to September 2026, against a year earlier

57.92 1.88 +3.35%
Market cap
$12.3B
P/E
118×
Fwd P/E
86.5×
Dividend yield
1.73%
F-score
7/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

American Healthcare REIT, Inc. (AHR) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Nov 6, 2026 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
10-Q Sep 30, 2026 P1I2: 3 added · 1 removed · 25 modified
P2I1A: no material changes, the filing says 		Share dilution
8-K Nov 5, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 18, 2026 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Sep 14, 2026 7.01 Regulation FD disclosure
8-K Sep 2, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K Sep 1, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 20, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Aug 10, 2026 8.01 Other events
8-K Aug 10, 2026 1.01 Entry into a material definitive agreement
10-Q Jun 30, 2026 P1I2: 3 added · 1 removed · 31 modified
P2I1A: no material changes, the filing says
8-K Aug 6, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jul 20, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jun 24, 2026 5.07 Submission of matters to a vote of security holders
8-K Jun 18, 2026 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K May 26, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K May 20, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K May 7, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Apr 1, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K/A Feb 3, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Mar 18, 2026 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 27, 2026 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 1 added · 20 removed · 39 modified
1A: 20 added · 49 removed · 72 modified
7: 15 added · 21 removed · 47 modified
8-K Feb 26, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Feb 3, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Dec 16, 2025 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Nov 24, 2025 8.01 Other events; 9.01 Financial statements and exhibits
8-K Nov 20, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Nov 6, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 18, 2025 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Aug 7, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 8, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
10-Q Sep 30, 2024
8-K Nov 12, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 5, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 13, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 21, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.